Stay updated on Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Study Details page content appears unchanged between the two screenshots.
    Difference
    0.4%
    Check dated 2025-10-27T21:08:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T08:58:13.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release.
    Difference
    0.1%
    Check dated 2025-09-29T07:30:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T23:19:34.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T20:05:02.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, as well as specific medical topics related to colorectal cancer and various antibodies and proteins. Additionally, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    2%
    Check dated 2025-08-31T12:52:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.